To sum up, this year our team embarked on a journey in the deep waters of synthetic biology, aiming to design our pANDORRA platform as a flexible and novel framework for circuit implementation and employ it to engineer a cell-type classifier to differentiate between healthy and colorectal cancer cells. We envision our design to serve as a stepping stone in the advancement of personalized cancer therapeutics and the expansion of the frontiers of biocomputing.